perindopril has been researched along with Chronic Disease in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.45) | 18.7374 |
| 1990's | 10 (32.26) | 18.2507 |
| 2000's | 14 (45.16) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belenkov, IuN; Danilogorskaia, IuA; Privalova, EV; Shchendrygina, AA; Zheleznykh, EF | 1 |
| Belenkov, YN; Chekneva, IS; Danilogorodskaya, YA; Privalova, EV; Shchendrygina, AA; Tishman, MI; Zheleznykh, EA | 1 |
| Harada, M; Inoue, N | 1 |
| Baron-Menguy, C; Cousin, M; Custaud, MA; Dumont, O; Guihot, AL; Henrion, D; Loufrani, L; Subra, JF; Toutain, B; Vessières, E | 1 |
| Goyal, R; Iyer, L; Mehta, A; Parmar, S; Shah, G | 1 |
| Aleksandrowicz-Wrona, E; Heleniak, Z; Lizakowski, S; Małgorzewicz, S; Renke, M; Rutkowski, B; Rutkowski, P; Sławińska-Morawska, M; Tylicki, L | 1 |
| Amemiya, M; Ando, Y; Asano, Y; Honma, S; Iimura, O; Kusano, E; Muto, S; Tanba, K; Yanagiba, S | 1 |
| Butorov, IV; Butorova, VG; Korneĭchuk, NN; Paraska, VI; Verbitskiĭ, ON | 1 |
| Abashidze, TB; Gorgoshidze, ML | 1 |
| Abashidze, TB; Lortkipanidze, RM | 1 |
| Adamus, J; Cleland, JG; Freemantle, N; Polonski, L; Taylor, J; Tendera, M | 1 |
| Clark, AL; Cleland, JG; Coletta, AP | 1 |
| Bordonali, T; Dei Cas, L; Metra, M; Milani, P; Nodari, S | 1 |
| Fujii, M; Horie, M; Nakae, I; Nishiyama, K; Ohnishi, M; Sakai, H; Tanaka, T; Tsutamoto, T; Wada, A; Yamamoto, T | 1 |
| Drexler, H; Hornig, B; Jeserich, M; Just, H; Kupfer, M; Lohmann, A; Münzel, T; Olschewski, M; Pape, L | 1 |
| Ogilvie, RI; Zborowska-Sluis, D | 1 |
| Blaysat, G; Compagnon, P; Desche, P; Elfertak, L; Henry, JP; Mulder, P; Richard, V; Scalbert, E; Thuillez, C | 1 |
| Chassing, A; Flammang, D; Waynberger, M | 1 |
| Antony, I; Desche, P; Lerebours, G; Robert, S; Violet, I; Weber, C | 1 |
| Barr, CS; Fenwick, M; MacFadyen, RJ; Struthers, AD; Sturrock, ND | 1 |
| Dratwa, M; Lachaud-Pettiti, V; Meyrier, A; Sennesael, J | 1 |
| Adamus, J; Cleland, JG; Freemantle, N; Gray, CS; Lye, M; O'Mahony, D; Polonski, L; Taylor, J; Tendera, M | 1 |
| Spinar, J; Vítovec, J | 1 |
| Chemla, D; Coirault, C; Fratacci, MD; Guérot, C; Hagège, A; Lecarpentier, Y | 1 |
| Baumbach, GL; Chillon, JM | 1 |
| Fomina, IG; Gaĭdamakina, NE; Georgadze, ZO; Matveev, VV; Nagieva, AZ; Sinitsyna, MG | 1 |
| De Rooy, SE; De Vries, OO; Jansen, PA; Raymakers, JA | 1 |
| Lees, KR; MacFadyen, RJ; Reid, JL | 1 |
| Bounhoure, JP | 1 |
| Bottineau, G; Bounhoure, JP; Garnham, J; Lapeyre, G; Lechat, P | 1 |
| Hodsman, GP; Howes, LG; Johnston, CI; Rowe, PR; Sumithran, E | 1 |
15 trial(s) available for perindopril and Chronic Disease
| Article | Year |
|---|---|
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease.
Topics: Adult; Amides; Antihypertensive Agents; Chronic Disease; Creatinine; Cross-Over Studies; Double-Blind Method; Female; Fibrosis; Fumarates; Humans; Kidney; Kidney Diseases; Male; Peptide Fragments; Perindopril; Pilot Projects; Procollagen; Renin; Transforming Growth Factor beta; Treatment Outcome | 2012 |
[Clinical and hemodynamical efficacy of prestarium and its role in the treatment of chronic pulmonary heart].
Topics: Angiotensin-Converting Enzyme Inhibitors; Bronchitis, Chronic; Case-Control Studies; Chronic Disease; Hemodynamics; Humans; Middle Aged; Perindopril; Pulmonary Heart Disease; Treatment Outcome | 2003 |
[Effect of a combination of teveten and prestarium in patients with chronic heart failure].
Topics: Acrylates; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Humans; Imidazoles; Male; Perindopril; Thiophenes | 2005 |
[Effect of prestarium in patients with chronic heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Arrhythmia, Sinus; Chronic Disease; Heart Failure; Humans; Middle Aged; Perindopril; Quality of Life | 2005 |
The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Perindopril; Survival Analysis; Treatment Outcome | 2006 |
Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril.
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Enalapril; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Perindopril; Radionuclide Imaging; Risk Factors; Stroke Volume; Sympathetic Nervous System; Treatment Outcome | 2008 |
Acceptability of perindopril in mild-to-moderate chronic congestive heart failure. Results of a long-term open study in 320 patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Exercise Test; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril; Treatment Outcome | 1993 |
Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure.
Topics: Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output, Low; Chronic Disease; Depression, Chemical; Female; Humans; Indoles; Kidney Function Tests; Male; Middle Aged; Perindopril | 1997 |
Fixed low-dose perindopril-indapamide combination in hypertensive patients with chronic renal failure.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Indoles; Male; Middle Aged; Perindopril; Renal Insufficiency | 1998 |
Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Echocardiography; Electrocardiography; Heart Failure; Humans; Perindopril; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Ventricular Function, Left | 1999 |
First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Dose-Response Relationship, Drug; Enalapril; Female; Heart Failure; Humans; Hypotension; Incidence; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors; Single-Blind Method; Stroke Volume | 2000 |
[Effects of perstarium on the systolic and diastolic functions of the myocardium in patients with chronic cardiac failure].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Perindopril | 2001 |
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Chronic Disease; Double-Blind Method; Enalapril; Female; Heart Failure; Heart Rate; Humans; Indoles; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Renin | 1991 |
[Perindopril and chronic heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Double-Blind Method; Exercise Test; Heart Failure; Hemodynamics; Humans; Indoles; Perindopril | 1991 |
[Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; Indoles; Middle Aged; Multicenter Studies as Topic; Perindopril; Pilot Projects; Random Allocation | 1989 |
16 other study(ies) available for perindopril and Chronic Disease
| Article | Year |
|---|---|
[Effect of 6-month therapy with perindopril A on structural-functional state of arterial vascular bed in patients with chronic heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Brachial Artery; Chronic Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Hyperemia; Male; Middle Aged; Perindopril; Vasodilation | 2014 |
[Effect of 12-Months Therapy With Perindopril A on Structural-Functional State of the Microcirculatory Vascular Bed in Patients With Chronic Heart Failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Heart Failure; Humans; Male; Microcirculation; Middle Aged; Perindopril; Severity of Illness Index; Vasodilation | 2015 |
Effect of perindopril on vasoreactivity in patients with hypertensive chronic cerebrovascular disease. A comparative analysis of different brain structures.
Topics: Acetazolamide; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Diabetes Complications; Diuretics; Female; Humans; Hypertension; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Middle Aged; Perindopril; Thalamic Diseases; Tomography, X-Ray Computed | 2008 |
Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Hypertension; Mesenteric Arteries; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits.
Topics: Acute Disease; Administration, Topical; Animals; Antihypertensive Agents; Cholinesterases; Chronic Disease; Disease Models, Animal; Glaucoma; Intraocular Pressure; Perindopril; Rabbits; Time Factors; Tonometry, Ocular | 2010 |
[Additive antiproteinuric effect of angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis].
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Chronic Disease; Collagen Type IV; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Male; Perindopril; Proteinuria; Tetrazoles; Treatment Outcome | 2003 |
Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cardiac Output, Low; Cardiology; Chronic Disease; Clinical Trials as Topic; Europe; Evidence-Based Medicine; Humans; Immunologic Factors; Perindopril; Societies, Medical; Telemedicine; Treatment Outcome | 2006 |
Clinical trials update from the World Congress of Cardiology 2006.
Topics: Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Humans; Immunotherapy; Perindopril; Treatment Outcome | 2007 |
Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril; Radial Artery; Vascular Resistance; Vasodilation | 1995 |
Effect of perindopril in pacing-induced canine models of acute and chronic heart failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Disease Models, Animal; Dogs; Heart Failure; Hemodynamics; Indoles; Perindopril; Vascular Capacitance | 1995 |
Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure. Effect of angiotensin converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Chronic Disease; Disease Models, Animal; Endothelium, Vascular; Heart Failure; Hemodynamics; Indoles; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Perindopril; Random Allocation; Rats; Rats, Wistar; Vasodilation | 1995 |
Acute and long-term efficacy of perindopril in severe chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Indoles; Male; Middle Aged; Perindopril | 1993 |
Angiotensin-converting enzyme inhibitor therapy improves respiratory muscle strength in patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Perindopril; Prospective Studies; Respiratory Muscles; Stroke Volume | 2001 |
Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arteriolar dilatation in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebral Arteries; Chronic Disease; Dilatation, Pathologic; Hypertension; Male; Perindopril; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2001 |
Blood pressure reduction after the first dose of captopril and perindopril.
Topics: Aged; Aged, 80 and over; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hypotension; Male; Perindopril; Risk Factors | 2001 |
Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels during perindopril therapy of chronic left ventricular failure in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Catecholamines; Chronic Disease; Female; Glycols; Indoles; Methoxyhydroxyphenylglycol; Myocardial Infarction; Myocardium; Organ Size; Perindopril; Rats; Rats, Inbred Strains | 1989 |